Skip to content

ALIZES PHARMA

Active Risk: not assessed
Private limited companyfounded 2026active for less than a yearRue du Bois St-Jean 15/1, 4102 Seraing, BelgiumKBO/BCE: BE 1040.385.871
Summary

ALIZES PHARMA is less than twelve months old; there is no public track record yet to compute a bankruptcy probability from. The company has been active since 2026 and the Belgian Official Gazette contains no insolvency or warning signals. No annual accounts have been filed with the National Bank.

Acts, filings and financial milestones

2026
23-09
Gazette deed Capital & shares · Miscellaneous
Declaration · Financial instrument · Power of attorney8 facts ▸
  • General meeting, 21-09-2026
  • Other provision, 14-09-2026
  • Declaration, “sole shareholder knowledge of report, dispense le Président d'en donner une lecture intégrale” (deed in French)
  • Declaration, “report annexed” (deed in French)
  • Financial instrument, “nominatif”, 200 (deed in French)
  • Declaration, “renonciation au droit de préférence, omitted” (deed in French)
  • Power of attorney (2 times)
  • Share issue, 200, “souscrire et libérer intégralement en espèces lors de la souscription” (deed in French)
20-07
Gazette deed Incorporation
Appointments: MAES PHARMCONSULT, MILEGRAND and 2 others · Permanent representatives: MAES Paul and LEGRAND Michaël Philippe Michel · Founder10 facts ▸
  • Incorporation, 16-07-2026
  • Founder, AQUILON PHARMACEUTICALS (comparant)
  • Founding capital, €15,000
  • Director appointment, MAES PHARMCONSULT (administrateur ordinaire)
  • Director appointment, MILEGRAND (administrateur ordinaire)
  • Director appointment, CATALDO Didier Daniel Claude Philippe (administrateur ordinaire)
  • Director appointment, NELLES Charles Henri Alex (administrateur ordinaire)
  • Permanent representative, MAES Paul
  • Permanent representative, LEGRAND Michaël Philippe Michel
  • Board meeting, “administrateur-délégué, gestion journalière et représentation pour cette gestion” (deed in French)
Gazette deed
2 of 2 deeds read